Financials
Five years in figures
| 2022 | 2021 | 2020 | 2019 | 2018 | ||
| Net sales | EUR million | 1,248.4 | 1,254.3 | 1,116.2 | 1,090.4 | 1,118.5 |
| of which outside Finland | EUR million | 1,136.0 | 1,142.0 | 1,021.9 | 977.5 | 1,006.6 |
| in percent of net sales | % | 91.0 | 91.0 | 91.5 | 89.6 | 90.0 |
| export from Finland | EUR million | 20.4 | 24.2 | 20.1 | 20.2 | 19.5 |
| Change of net sales, % | % | -0.5 | 12.4 | 2.4 | -2.5 | -5.6 |
| Gross profit | EUR million | 555.9 | 539.8 | 452.0 | 447.3 | 485.1 |
| % of net sales | % | 44.5 | 43.0 | 40.5 | 41.0 | 43.4 |
| EBIT | EUR million | 134.7 | 142.8 | 98.0 | 60.1 | 91.6 |
| % of net sales | % | 10.8 | 11.4 | 8.8 | 5.5 | 8.2 |
| Comparable EBIT | EUR million | 151.0 | 154.2 | 109.0 | 77.8 | 100.8 |
| % of net sales | % | 12.1 | 12.3 | 9.8 | 7.1 | 9.8 |
| Change in fair value of biological assets | EUR million | 1.1 | 1.3 | 0.7 | -0.2 | 2.0 |
| Financial items net | EUR million | -11.7 | 0.0 | -8.9 | 3.4 | 9.4 |
| % of net sales | % | -0.9 | 0.0 | -0.8 | 0.3 | 0.8 |
| Profit before taxes | EUR million | 124.1 | 144.1 | 89.8 | 63.2 | 103.0 |
| % of net sales | % | 9.9 | 11.5 | 8.0 | 5.8 | 9.2 |
| Income tax | EUR million | -25.0 | -56.5 | -21.3 | -10.8 | 21.1 |
| Profit for the period attributable to the equity holders in the parent company | EUR million | 98.2 | 86.6 | 67.6 | 51.7 | 81.6 |
| % of net sales | % | 7.9 | 6.9 | 6.1 | 4.7 | 7.3 |
| Non-controlling interests | EUR million | 0.9 | 0.9 | 0.8 | 0.7 | 0.2 |
| Employee benefits | EUR million | 289.0 | 293.7 | 262.9 | 311.9 | 307.9 |
| Depreciation, amortization and impairment | EUR million | 59.4 | 61.6 | 76.1 | 59.6 | 43.8 |
| % of net sales | % | 4.8 | 4.9 | 6.8 | 5.5 | 3.9 |
| Cash flow from operating activities | EUR million | -61.4 | 122.9 | 199.2 | 96.5 | 105.9 |
| Capital expenditure | EUR million | 48.1 | 34.4 | 30.0 | 40.0 | 46.2 |
| % of net sales | % | 3.9 | 2.7 | 2.7 | 3.7 | 4.1 |
| Research and development costs in income statement | EUR million | 20.8 | 15.5 | 16.5 | 18.4 | 18.4 |
| % of net sales | % | 1.7 | 1.2 | 1.5 | 1.7 | 1.6 |
| Capitalized development costs | EUR million | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Equity attributable to equity holders of the parent company | EUR million | 831.6 | 812.1 | 757.8 | 760.9 | 1,207.0 |
| Non-controlling interest | EUR million | 4.1 | 4.2 | 3.8 | 3.6 | 2.7 |
| Equity total | EUR million | 835.6 | 816.3 | 761.6 | 764.5 | 1,209.7 |
| Net interest-bearing debt | EUR million | 325.3 | 144.4 | 143.7 | 261.1 | 135.4 |
| Working capital | EUR million | 337.2 | 164.5 | 134.2 | 194.4 | 197.0 |
| Balance sheet total | EUR million | 1,585.4 | 1,435.5 | 1,342.0 | 1,364.3 | 1,719.2 |
| Return on investment | % | 12.1 | 15.3 | 9.9 | 6.0 | 7.9 |
| Return on equity | % | 12.0 | 11.1 | 9.0 | 5.3 | 6.6 |
| Equity ratio | % | 52.7 | 56.9 | 56.8 | 56.0 | 70.4 |
| Net gearing | % | 38.9 | 17.7 | 18.9 | 34.2 | 11.2 |
| Personnel (FTE), average | 6,273 | 6,081 | 6,104 | 6,840 | 7,304 | |
| Personnel, end of period | 6,595 | 6,690 | 6,411 | 6,984 | 7,706 | |
| of which outside Finland | 5,432 | 5,579 | 5,348 | 5,852 | 6,581 |